🧬Requirements for Patent Applications with Nucleotide Sequence Disclosures
Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request; Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures
Summary
The United States Patent and Trademark Office (USPTO), as required by the Paperwork Reduction Act of 1995, invites comments on the extension and revision of an existing information collection: 0651- 0024 (Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures). The purpose of this notice is to allow 60 days for public comments preceding submission of the information collection to the Office of Management and Budget (OMB).
Agencies
- Commerce Department
- Patent and Trademark Office
Business Impact
$$$ - High
The document outlines compliance requirements for businesses submitting patent applications that include nucleotide or amino acid sequences. There is a clear burden of time and associated costs ($80.46 million annually) for compliance with these regulations, making it a significant factor for business executives involved in patenting.